Newsroom

Welcome to the IVX Health Newsroom. Here, you can find the latest news on our company, including future market expansions, leadership updates, new formulary offerings and more.

Jacksonville, Dec. 13, 2022 /PRNewswire/ -- IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with Crohn's disease, multiple sclerosis, rheumatoid arthritis, and other complex chronic conditions, today announced its expansion in the greater Jacksonville area with the opening of a new location in Jacksonville Beach.

Raleigh, NC, Nov. 10, 2022 /PRNewswire/ -- IVX Health today announced the opening of six new centers across North Carolina – with three locations in each of the greater Charlotte and Raleigh-Durham areas.

Nashville, Tenn., Oct. 4, 2022 /PRNewswire/ -- Modern Healthcare has named IVX Health as one of the Best Places to Work in Healthcare in 2022 for the fourth consecutive year.

Palm Beach, Fla., Sept. 21, 2022 /PRNewswire/ -- IVX Health today announced the opening of three new outpatient infusion centers in the greater Palm Beach area.

HARTFORD, Conn., August 30, 2022 /PRNewswire/ -- IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple sclerosis, Crohn’s disease, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of two infusion centers in the greater Hartford and New Haven areas, with plans to open more centers in the state of Connecticut over the coming year.

NASHVILLE, Tenn., July 19, 2022 /PRNewswire/ -- IVX Health proudly announced today it has achieved national accreditation through the Accreditation Commission for Health Care (ACHC) for the services of Ambulatory Infusion Centers.

SARASOTA, Fla., June 9, 2022 /PRNewswire/ -- IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple sclerosis, Crohn's disease, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of a new infusion center in the greater Sarasota-Bradenton area.

DAYTONA BEACH, Fla., April 7, 2022 /PRNewswire/ -- IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple sclerosis, Crohn's disease, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of two new centers in the greater Daytona Beach area.

Fort Myers, Fla., Feb. 17, 2022 /Business Wire/ -- IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple sclerosis, Crohn’s disease, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of three new centers in the Southwest Florida region this spring.

NASHVILLE, Tenn., Feb. 8, 2022 /Business Wire/ -- –IVX Health, a national provider of infusion and injection therapy for patients with complex chronic conditions, announced today the expansion of its injection formulary with the addition of Leqvio® (inclisiran), a new FDA-approved therapy by Novartis Pharmaceuticals Corporation indicated for the treatment of adult patients with clinical atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH) who require additional LDL-C lowering.

Media Inquiries

Chase Pattison
Vice President, Marketing
[email protected]

Headquarters

IVX Health
214 Centerview Drive
Suite 250
Brentwood, TN 37027

Click here to find an IVX Health center near you.

Menu